硫普罗宁本身的药代动力学尚不清楚。 - Suppr

Suppr

超能文献

The pharmacokinetics of tiopronin as such is unknown.

作者信息

Carlsson M S, Denneberg T, Emanuelsson B M, Kågedal B, Lindgren S

出版信息

Eur J Clin Pharmacol. 1994;46(6):576-7. doi: 10.1007/BF00196122.

DOI:10.1007/BF00196122

PMID:7995332

Abstract

摘要

相似文献

The pharmacokinetics of tiopronin as such is unknown.硫普罗宁本身的药代动力学尚不清楚。

Eur J Clin Pharmacol. 1994;46(6):576-7. doi: 10.1007/BF00196122.

The pharmacokinetics of tiopronin and its principal metabolite (2-mercaptopropionic acid) after oral administration to healthy volunteers.口服给予健康志愿者后，硫普罗宁及其主要代谢产物（2-巯基丙酸）的药代动力学。

Eur J Clin Pharmacol. 1992;43(1):93-5. doi: 10.1007/BF02280762.

Pharmacokinetics of tiopronin after repeated oral administration in rheumatoid arthritis.硫普罗宁在类风湿关节炎患者重复口服给药后的药代动力学

Fundam Clin Pharmacol. 1995;9(2):205-6. doi: 10.1111/j.1472-8206.1995.tb00283.x.

Pharmacokinetics of oral tiopronin.口服硫普罗宁的药代动力学

Eur J Clin Pharmacol. 1993;45(1):79-84. doi: 10.1007/BF00315354.

Changes in clearance create pharmacokinetic pitfalls as illustrated by studies on tiopronin.清除率的变化会造成药代动力学方面的隐患，如关于硫普罗宁的研究所显示的那样。

Eur J Clin Pharmacol. 1994;46(6):575. doi: 10.1007/BF00196121.

Pharmacokinetics of intravenous 2-mercaptopropionylglycine in man.静脉注射2-巯基丙酰甘氨酸在人体中的药代动力学。

Eur J Clin Pharmacol. 1990;38(5):499-503. doi: 10.1007/BF02336691.

Efficacy of two-route chemotherapy using intraperitoneal neocarzinostatin and its antidote, intravenous tiopronin, for peritoneally disseminated tumors in mice.使用腹腔注射新制癌菌素及其解毒剂静脉注射硫普罗宁的双途径化疗对小鼠腹膜播散性肿瘤的疗效。

Jpn J Cancer Res. 1989 Mar;80(3):283-9. doi: 10.1111/j.1349-7006.1989.tb02306.x.

Quantitative determination of tiopronin in human plasma by LC-MS/MS without derivatization.无需衍生化，采用液相色谱-串联质谱法对人血浆中的硫普罗宁进行定量测定。

Biomed Chromatogr. 2012 Jul;26(7):839-43. doi: 10.1002/bmc.1738. Epub 2011 Nov 4.

Glutathione-mediated drug release from Tiopronin-conjugated gold nanoparticles for acute liver injury therapy.基于谷胱甘肽的巯基药物释放系统用于替普瑞酮偶联金纳米颗粒治疗急性肝损伤

Int J Pharm. 2013 Mar 25;446(1-2):112-8. doi: 10.1016/j.ijpharm.2013.01.073. Epub 2013 Feb 14.

Simultaneous determination of tiopronin and its primary metabolite in plasma and ocular tissues by HPLC.采用高效液相色谱法同时测定血浆和眼组织中的硫普罗宁及其主要代谢产物。

Biomed Chromatogr. 2019 Feb;33(2):e4375. doi: 10.1002/bmc.4375. Epub 2018 Sep 26.

引用本文的文献

Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria.增加半胱氨酸结合巯基药物剂量对胱氨酸尿症患者胱氨酸容量的影响。

Urolithiasis. 2019 Dec;47(6):549-555. doi: 10.1007/s00240-019-01128-y. Epub 2019 Apr 13.

Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.硫普罗宁预防索拉非尼及抗病毒治疗所致晚期乙型肝炎病毒相关肝细胞癌肝毒性的前瞻性分析

Med Oncol. 2015 Oct;32(10):238. doi: 10.1007/s12032-015-0684-x. Epub 2015 Sep 2.

本文引用的文献

Pharmacokinetics of oral tiopronin.口服硫普罗宁的药代动力学

Eur J Clin Pharmacol. 1993;45(1):79-84. doi: 10.1007/BF00315354.

Eur J Clin Pharmacol. 1994;46(6):575. doi: 10.1007/BF00196121.

Alternative treatment of cystinuria with alpha-merkaptopropionylglycine, Thiola.

Proc Eur Dial Transplant Assoc. 1983;20:427-33.

Determination of 2-mercaptopropionylglycine in plasma and urine by high-performance liquid chromatography.高效液相色谱法测定血浆和尿液中的2-巯基丙酰甘氨酸

J Chromatogr. 1986 Aug 2;380(2):301-11. doi: 10.1016/s0378-4347(00)83658-0.

High-performance liquid chromatography of 2-mercaptopropionylglycine and its metabolite 2-mercaptopropionic acid in plasma and urine after treatment with thiopronine.用硫普罗宁治疗后血浆和尿液中2-巯基丙酰甘氨酸及其代谢产物2-巯基丙酸的高效液相色谱分析

J Chromatogr. 1987 Jul 3;417(2):261-7. doi: 10.1016/0378-4347(87)80119-6.

Pharmacokinetics of intravenous 2-mercaptopropionylglycine in man.静脉注射2-巯基丙酰甘氨酸在人体中的药代动力学。

Eur J Clin Pharmacol. 1990;38(5):499-503. doi: 10.1007/BF02336691.

The relevance of residence time theory to pharmacokinetics.

Eur J Clin Pharmacol. 1992;43(6):571-9. doi: 10.1007/BF02284953.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验